Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update
May 04, 2020 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif. , May 04, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
April 27, 2020 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update...
Corcept Therapeutics Publishes Abstract in The Journal of the Endocrine Society
April 01, 2020 08:30 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., April 01, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs that treat...
Corcept Therapeutics Appoints Gregg Alton to Board of Directors
March 12, 2020 08:30 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
Corcept Therapeutics Announces Fourth Quarter And Full-Year 2019 Audited Financial Results And Provides Corporate Update
February 20, 2020 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
Corcept Therapeutics to Announce Audited Financial Results, Provide Corporate Update and Host Conference Call
February 13, 2020 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report its audited 2019 fourth quarter and full-year financial results...
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2019 Preliminary Selected Financial Results; Provides 2020 Revenue Guidance
January 30, 2020 16:05 ET
|
Corcept Therapeutics Incorporated
2019 revenue of $306.5 million, an increase of 22 percent from 2018Fourth quarter revenue of $87.9 million, an increase of 32 percent from fourth quarter 2018Cash and investments at December 31, 2019,...
Corcept Therapeutics Announces Third quarter 2019 Financial Results and provides corporate update
November 07, 2019 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
October 31, 2019 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update...
Corcept Therapeutics Appoints Kimberly Park to Board of Directors
September 18, 2019 08:30 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...